Sign In
Buy DVAX
$15.50
+0 (+0%)
At Close: May 08, 2026
The
NIRF Ranking 2020: Here’s the list of top Indian institutes
12:31pm, Friday, 12'th Jun 2020
What differs the best institute in the overall category from others is that it is not just competing with institutes of its own domain of study but also with institutes of all streams, colleges, and e
PU slips down NIRF ranking by ten spots, improves in two areas
04:19am, Friday, 12'th Jun 2020
However, the university did improve its score and rankings in the Pharmacy and Management category and even figured in the law category for the first time.
NIRF: IIT Madras best educational institution in country; 7 IITs in top 10, IISc and JNU best universities
06:14pm, Thursday, 11'th Jun 2020
The Human Resource Development (HRD) Ministry's National Institutional Ranking Framework (NIRF) announced the rankings on Thursday. The annual rankings are usually announced in April but had to be pos
NIRF ranking 2020: JNU, Jamia Millia Islamia among top 10 universities in India
06:09pm, Thursday, 11'th Jun 2020
The Human Resource Development (HRD) Ministry's National Institutional Ranking Framework (NIRF) announced the rankings on Thursday.
7 Great Biotech Stocks to Buy and Hold Now
02:55pm, Thursday, 11'th Jun 2020
As investors begin to turn their attention away from Covid-19 and the novel coronavirus, these biotech stocks present excellent opportunities.
IIT Madras retains top spot as India's best institute in NIRF Rankings
12:42pm, Thursday, 11'th Jun 2020
Institutes like IISc, IIT Madras and IIM Ahmedabad claimed the top spots in other categories such as universities, and engineering and management institutes
Dynavax Closes Enrollment in Renal Disease Study on Heplisav-B
01:30pm, Wednesday, 10'th Jun 2020
Dynavax (DVAX) is developing its hepatitis B vaccine, Heplisav-B, in patients with end-stage renal disease undergoing hemodialysis in a phase I study.
Dynavax Completes Enrollment Of Clinical Trial Evaluating HEPLISAV-B In Patients Undergoing Hemodialysis
12:01pm, Tuesday, 09'th Jun 2020Dynavax Completes Enrollment of Clinical Trial Evaluating HEPLISAV-B in Patients Undergoing Hemodialysis | MarketScreener
12:01pm, Tuesday, 09'th Jun 2020Dynavax Completes Enrollment of Clinical Trial Evaluating HEPLISAV-B in Patients Undergoing Hemodialysis
12:00pm, Tuesday, 09'th Jun 2020
The trial enrolled 119 patients with end-stage renal disease undergoing hemodialysis Final immunogenicity data anticipated in Q4 2020 EMERYVILLE, Calif., June 09, 2020 --.
ChemoCentryx: Avacopan's Attractive Value Proposition (NASDAQ:CCXI)
10:00am, Monday, 08'th Jun 2020
ChemoCentryx management is still delivering strong execution. Despite the recent announcement that the LUMINA-1 trial failed to meet its primary endpoint, there
The more COVID-19 vaccines, the merrier | The Japan Times
09:00am, Saturday, 06'th Jun 2020
With companies and universities around the world working flat out, it's likely we'll end up with a few coronavirus vaccines, not just one.
Why the Jobs Report Isn’t Quite as Good as It Seems
01:39am, Saturday, 06'th Jun 2020
While suggesting that a recovery is beginning, the jobs report should be seen in the context of the unprecedented plunge in the previous two months.
